| Latest Forum Topics / QT Vascular |
|
|
QT Vascular Going BIG
|
|||||
|
notsostupid
Veteran |
07-Mar-2015 18:41
|
||||
|
x 0
x 0 Alert Admin |
Cordis sold. I saw it coming when JnJ sought buyer for it last Aug. Now this one in initial stage of seeking M&A. I'm also seeing it coming. My gut feel only. | ||||
| Useful To Me Not Useful To Me | |||||
|
notsostupid
Veteran |
07-Mar-2015 02:26
|
||||
|
x 0
x 0 Alert Admin |
S$36m instead | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
notsostupid
Veteran |
06-Mar-2015 20:02
|
||||
|
x 0
x 0 Alert Admin |
I thought 2014 sales profit was US$3.3m. The total loss was due to R&D which is a good expenditure and some one-off and non-recurring expenditures like e.g. IPO.
2015 sales revenue forecasted to be around US36m. Possibility of becoming profitable.
Acquisition is all about the products' potential and future earnings the products can generate for long term. Some already got acquired without having revenue.
|
||||
| Useful To Me Not Useful To Me | |||||
|
halleluyah
Supreme |
06-Mar-2015 19:22
|
||||
|
x 0
x 0 Alert Admin |
Wait see can reach 0.265 last low then gt u-turn boh...every q is in a loss...haizz | ||||
| Useful To Me Not Useful To Me | |||||
|
notsostupid
Veteran |
06-Mar-2015 18:59
|
||||
|
x 0
x 0 Alert Admin |
Quote. Cardinal's chief executive, George Barrett, said the company may make more acquisitions in cardiology and endovascular treatment as well as in the trauma and wound care segment. "Those are areas where we could see opportunities to fill out the portfolio," Barrett said in an interview. Unquote Cordis selling QT's products. QT stands a chance to be acquired also? | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
francisd
Master |
06-Mar-2015 09:28
Yells: "BUY LOW SELL HIGH" |
||||
|
x 0
x 0 Alert Admin |
Good price to go in close to its 52 week lows..... Cheers.   |
||||
| Useful To Me Not Useful To Me | |||||
|
notsostupid
Veteran |
06-Mar-2015 07:32
|
||||
|
x 0
x 0 Alert Admin |
Medical industry seems to be in acquisition mode. Matter of time only. Great potential here. | ||||
| Useful To Me Not Useful To Me | |||||
|
notsostupid
Veteran |
05-Mar-2015 00:10
|
||||
|
x 0
x 0 Alert Admin |
Quote. Cardinal Health buy Johnson & Johnson' s Cordis vascular technology unit for US$1.9 billion and the acquisition would boost 2017 earnings by 20 US cents per share. Cardinal Health gained 1.4 per cent to US$89.26 and JNJ added 0.6 per cent to US$103.15. Any implication for QT Vascular? | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
playerbanker
Member |
02-Mar-2015 12:20
|
||||
|
x 0
x 0 Alert Admin |
Break below 30cts already , most ipo sellers all out may see 24 cts soon
|
||||
| Useful To Me Not Useful To Me | |||||
|
vivivava
Veteran |
02-Mar-2015 10:25
|
||||
|
x 0
x 0 Alert Admin |
ipo price nw....think the low was 0.265 or 0.26 |
||||
| Useful To Me Not Useful To Me | |||||
|
Jimmykohkk
Master |
28-Feb-2015 18:35
|
||||
|
x 0
x 0 Alert Admin |
our company is identifying targets < our company is the identified target :) unless the target they going to buy over is a famous one
|
||||
| Useful To Me Not Useful To Me | |||||
|
notsostupid
Veteran |
28-Feb-2015 18:33
|
||||
|
x 0
x 0 Alert Admin |
Is it good news or no event? | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
notsostupid
Veteran |
28-Feb-2015 18:31
|
||||
|
x 0
x 0 Alert Admin |
Quoted ? In exploratory stages for M&A opportunities. Our channel checks have indicated that the group is in the initial stages of identifying possible targets. | ||||
| Useful To Me Not Useful To Me | |||||
|
charliel3ong
Senior |
26-Feb-2015 12:15
|
||||
|
x 0
x 0 Alert Admin |
am new to this counter. any good to vest in this one? |
||||
| Useful To Me Not Useful To Me | |||||
|
vivivava
Veteran |
26-Feb-2015 09:25
|
||||
|
x 0
x 0 Alert Admin |
http://www.nextinsight.net/index.php/story-archive-mainmenu-60/927-2015/9698-qt-vascular-revenue-surged-1407-to-us132-million-in-2014 |
||||
| Useful To Me Not Useful To Me | |||||
|
vivivava
Veteran |
26-Feb-2015 09:15
|
||||
|
x 0
x 0 Alert Admin |
Both FY2014 revenue and net losses are in line with our expectations.  QTVC' s revenue increased by 140% yoy to US$13.2m in FY2014. The increase was mainly due to an improvement in the group' s Chocolate PTA and Glider PTCA sales through distributions and direct coronary sales in the United States.     The group sold 30,344 units products (+194%) yoy in FY2014. Of which, 89.2% of sales came from the US, 8.8% from Asia Pacific and 2.0% from Europe.  Cost of sales increased by US$3.9m (+67.7%) yoy to US$9.8m in FY2014 mainly due to the increased sales of Chocolate PTA and Glider PTCA. In addition, there are some short-term increases in unit costs primarily attributable to materials and overhead expenses in the second half of the year. The increase was partially offset by continued pricing improvements from the group' s suppliers.  QTVC incurred US$9.7m in research and development expenses in FY2014 but was offset by capitalization of development expenses of US$3.0 million during the year.  We maintain our BUY recommendation on QT Vascular, target price of S$0.60, pending an analyst briefing later.      Regards,  Bennett Lee  UOB Kay Hian Research  DID: +65-6590 6616 Email:  [email protected] |
||||
| Useful To Me Not Useful To Me | |||||
|
notsostupid
Veteran |
25-Feb-2015 21:07
|
||||
|
x 0
x 0 Alert Admin |
www.stockbank.com.sg | ||||
| Useful To Me Not Useful To Me | |||||
|
notsostupid
Veteran |
25-Feb-2015 21:04
|
||||
|
x 0
x 0 Alert Admin |
Check out www.stockbank.com
|
||||
| Useful To Me Not Useful To Me | |||||
|
HVRRVH
Elite |
25-Feb-2015 20:56
|
||||
|
x 0
x 0 Alert Admin |
Any link? Would like to read. My last purchase price is 30.5 cents. Average holding price is 32 cents. Going in with mindset of holding this for at least a year. 
|
||||
| Useful To Me Not Useful To Me | |||||
|
notsostupid
Veteran |
25-Feb-2015 20:53
|
||||
|
x 0
x 0 Alert Admin |
One more analyst just today gave a 'Buy' rating with target price of $0.60. Make sense.
|
||||
| Useful To Me Not Useful To Me | |||||

